PABLO MARTINEZ CAMBLOR-rekin lankidetzan egindako argitalpenak (10)

2019

  1. Corrigendum: H3K4me1 marks DNA regions hypomethylated during aging in human stem and differentiated cells

    Genome research

2017

  1. Cisplatin resistance in cell models evaluation of metallomic and biological predictive biomarkers to address early therapy failure

    Metallomics, Vol. 9, Núm. 5, pp. 564-574

2015

  1. H3K4me1 marks DNA regions hypomethylated during aging in human stem and differentiated cells

    Genome Research, Vol. 25, Núm. 1, pp. 27-40

2013

  1. A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma

    Journal of Molecular Medicine, Vol. 91, Núm. 8, pp. 939-950

  2. DNA Methylation Dynamics in Blood after Hematopoietic Cell Transplant

    PLoS ONE, Vol. 8, Núm. 2

  3. DNA methylation signatures identify biologically distinct thyroid cancer subtypes

    Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 7, pp. 2811-2821

  4. Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors

    Cancer Research, Vol. 73, Núm. 1, pp. 395-405

  5. Long-term biomonitoring of breast cancer patients under adjuvant chemotherapy: the comet assay as a possible predictiv

    Mutagenesis, Vol. 28, Núm. 1, pp. 39-48

2012

  1. A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer

    European Journal of Cancer, Vol. 48, Núm. 14, pp. 2270-2281

  2. A promoter DNA demethylation landscape of human hematopoietic differentiation

    Nucleic Acids Research, Vol. 40, Núm. 1, pp. 116-131